Gadeta
Development of innovative immunotherapies for cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€28—42m (Dealroom.co estimates Mar 2016.)
Utrecht Utrecht (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
€7.0m | Series A | ||
€310k | Grant | ||
N/A | Early VC | ||
* | N/A | Acquisition | |
| Total Funding | €7.3m | ||
Related Content
Recent News about Gadeta
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.